Volume | 110 794 |
|
|||||
Actualités | - | ||||||
Maximum Haut | 8,29 | Bas Haut |
|||||
Minimum Bas | 6,90 |
Nom Action | Symbole Action | Marché | Type |
---|---|---|---|
Nuvectis Pharma Inc | NVCT | NASDAQ | Action ordinaire |
Ouverture | Plus Bas | Plus Haut | Prix de clôture | Clôture Veille |
---|---|---|---|---|
6,93 | 6,90 | 8,29 | 8,14 | 6,76 |
Transactions Totales | Volume échangé | VWAP | Volume Financier | Volume en moyenne | Sur 52 semaines |
---|---|---|---|---|---|
1 769 | 110 794 | US$ 7,69 | US$ 851 687 | - | 5,92 - 18,65 |
Dernière Transaction | Type | Quantités échangées | Prix transaction | Devise |
---|---|---|---|---|
00:48:39 | formt | 1 000 | US$ 7,70 | USD |
Bilan Comptable
Capitalisation Boursière | Actions en Circulation | Float | Chiffre d'affaires | Bénéfice/Perte | BPA | Ratio Cours sur Bénéfices |
---|---|---|---|---|---|---|
143,93M | 17,77M | - | 0 | -22,26M | -1,25 | - |
Short Interest | Dividendes Par Action | Rendement du Dividende | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
plus d’informations financières »
Actualités Action Nuvectis Pharma
Date | Heure | Source | Titre |
---|---|---|---|
05/3/2024 | 23:20 | Edgar (US Regulatory) | Form 10-K - Annual report [Section 13 and 15(d), not S-K.. |
05/3/2024 | 14:17 | Edgar (US Regulatory) | Form 8-K - Current report |
05/1/2024 | 22:31 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
05/1/2024 | 22:30 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
08/11/2023 | 14:39 | Edgar (US Regulatory) | Form 8-K - Current report |
08/11/2023 | 13:45 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
12/9/2023 | 14:16 | Edgar (US Regulatory) | Form 8-K - Current report |
17/8/2023 | 15:18 | Edgar (US Regulatory) | Form 8-K - Current report |
09/8/2023 | 22:51 | Edgar (US Regulatory) | Form S-8 - Securities to be offered to employees in employee.. |
09/8/2023 | 22:29 | Edgar (US Regulatory) | Form 8-K - Current report |
09/8/2023 | 22:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
03/7/2023 | 14:00 | Edgar (US Regulatory) | Form 8-K - Current report |
Forum Action Nuvectis Pharma
Aucune Discussion TrouvéeAjouter une Discussion
Historiques Nuvectis Pharma Inc
Période | Ouver. | Haut | Bas | VWAP | Moyenne Vol. Quot. | Variation | % |
---|---|---|---|---|---|---|---|
1 semaine | 6,52 | 8,29 | 5,92 | 6,31 | 99 684 | 1,18 | 18,10% |
1 mois | 7,82 | 8,29 | 5,92 | 6,66 | 64 853 | -0,12 | -1,53% |
3 mois | 6,99 | 12,10 | 5,92 | 8,50 | 100 574 | 0,71 | 10,16% |
6 mois | 9,12 | 12,10 | 5,92 | 8,34 | 80 723 | -1,42 | -15,57% |
1 an | 14,75 | 18,65 | 5,92 | 11,10 | 68 386 | -7,05 | -47,80% |
3 ans | 3,95 | 20,92 | 3,08 | 8,03 | 208 091 | 3,75 | 94,94% |
5 ans | 3,95 | 20,92 | 3,08 | 8,03 | 208 091 | 3,75 | 94,94% |